Back to News
Market Impact: 0.6

Warren Buffett Detailed Fundamental Analysis

LRCXBRK.ABRK.BNDAQ
Company FundamentalsAnalyst InsightsTechnology & InnovationCapital Returns (Dividends / Buybacks)
Warren Buffett Detailed Fundamental Analysis

Validea's guru fundamental report indicates LAM RESEARCH CORP (LRCX) receives a 100% rating based on their Patient Investor model, which is based on the investment strategy of Warren Buffett; the strategy seeks firms with predictable profitability, low debt, and reasonable valuations. The analysis suggests LRCX, a large-cap growth stock in the Semiconductors industry, strongly aligns with Buffett's criteria, excelling in earnings predictability, debt service, return on equity, and free cash flow.

Analysis

Lam Research Corp (LRCX) has garnered a perfect 100% rating from Validea's Patient Investor model, which emulates the investment strategy of Warren Buffett, indicating strong conviction based on the firm's fundamentals and valuation. This model specifically seeks companies with long-term, predictable profitability, low debt, and reasonable valuations, criteria that LRCX, a large-cap growth stock in the Semiconductors industry, appears to meet comprehensively. The analysis highlights that LRCX passed all specific tests within this strategy, including earnings predictability, debt service, return on equity, return on total capital, free cash flow generation, effective use of retained earnings, share repurchase activity, initial rate of return, and expected return. Such a high score, particularly one exceeding the 90% threshold for strong interest, underscores the company's alignment with a disciplined, value-oriented investment approach.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

strongly positive

Sentiment Score

0.85

Ticker Sentiment

BRK.A0.00
BRK.B0.00
LRCX0.85
NDAQ0.00

Key Decisions for Investors

  • Investors may find Lam Research Corp (LRCX) an attractive long-term holding, given its exceptional alignment with Warren Buffett's stringent investment criteria and perfect score in the Patient Investor model.
  • The company's demonstrated strength across all fundamental metrics, including predictable earnings, manageable debt, high returns on capital, robust free cash flow, and shareholder-friendly capital allocation via share repurchases, warrants positive consideration.
  • While the fundamental outlook presented is highly favorable, investors should still perform independent valuation analysis and monitor semiconductor industry cyclicality, as these factors could influence LRCX's future performance despite its current strong fundamental standing.